Profund Advisors LLC Vir Biotechnology, Inc. Transaction History

Profund Advisors LLC

$2.67 Billion
Q4 2024

A detailed history of Profund Advisors LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 27,510 shares of VIR stock, worth $265,471. This represents 0.01% of its overall portfolio holdings.

Number of Shares

27,510

Previous 37,464 26.57%

Holding current value

$265,471

Previous $280,000 28.21%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$6.74 - $10.17 $67,089 - $101,232	-9,954 Reduced 26.57%	27,510 $201,000
Q3 2024 Nov 13, 2024	BUY	$7.26 - $10.7 $53,259 - $78,495	7,336 Added 24.35%	37,464 $280,000
Q2 2024 Aug 13, 2024	SELL	$7.63 - $12.66 $312,814 - $519,034	-40,998 Reduced 57.64%	30,128 $268,000
Q1 2024 May 08, 2024	BUY	$8.6 - $11.9 $20,149 - $27,881	2,343 Added 3.41%	71,126 $720,000
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $172,698 - $229,003	-22,255 Reduced 24.45%	68,783 $691,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $283,605 - $763,933	31,029 Added 51.71%	91,038 $853,000
Q2 2023 Aug 10, 2023	BUY	$23.2 - $27.29 $21,112 - $24,833	910 Added 1.54%	60,009 $1.47 Million
Q1 2023 May 11, 2023	BUY	$22.26 - $30.85 $1.02 Million - $1.42 Million	45,932 Added 348.84%	59,099 $1.38 Million
Q4 2022 Feb 02, 2023	SELL	$19.96 - $28.22 $4,890 - $6,913	-245 Reduced 1.83%	13,167 $333,000
Q3 2022 Nov 04, 2022	SELL	$18.26 - $31.1 $1,515 - $2,581	-83 Reduced 0.62%	13,412 $259,000
Q2 2022 Aug 01, 2022	BUY	$19.08 - $26.7 $49,302 - $68,992	2,584 Added 23.68%	13,495 $344,000
Q1 2022 May 10, 2022	SELL	$21.19 - $40.01 $25,343 - $47,851	-1,196 Reduced 9.88%	10,911 $281,000
Q4 2021 Feb 08, 2022	SELL	$30.97 - $54.03 $46,857 - $81,747	-1,513 Reduced 11.11%	12,107 $507,000
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $18,741 - $29,287	537 Added 4.1%	13,620 $593,000
Q2 2021 Aug 12, 2021	SELL	$38.75 - $51.0 $1,666 - $2,193	-43 Reduced 0.33%	13,083 $619,000
Q1 2021 May 14, 2021	SELL	$26.34 - $83.07 $33,004 - $104,086	-1,253 Reduced 8.71%	13,126 $673,000
Q4 2020 Feb 09, 2021	BUY	$25.51 - $43.38 $35,127 - $59,734	1,377 Added 10.59%	14,379 $385,000
Q3 2020 Nov 13, 2020	BUY	$28.28 - $53.6 $367,696 - $696,907	13,002 New	13,002 $446,000

Others Institutions Holding VIR

# of Institutions

230

Shares Held

90.1M

Call Options Held

1.28M

Put Options Held

235K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.28B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Vir Biotechnology, Inc. Transaction History